Pain Relief Patch

Description

The product is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the adjuvant treatment of pain associated with the following conditions: cervical spondylosis, frozen shoulder, lumbar disc herniation, rheumatoid arthritis, and injuries to bone, joint, or soft tissue.

There are no teratogenic or nonteratogenic effects reported.

Dosage and Administration

For the temporary relief of minor aches and pains, the recommended dosage should be determined based on the specific needs of the patient. Healthcare professionals are advised to assess the severity of the symptoms and individual patient factors when prescribing.

The medication may be administered orally, and the dosing range typically falls within the standard guidelines for over-the-counter analgesics. It is essential to follow the manufacturer's instructions regarding the exact dosage and frequency of administration.

Patients should be instructed to take the medication at regular intervals, ensuring not to exceed the maximum daily dosage as specified in the prescribing information. If symptoms persist or worsen, a healthcare professional should be consulted for further evaluation and management.

Proper preparation and administration techniques should be emphasized, including the importance of taking the medication with food or water if indicated, to enhance tolerability and effectiveness.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on wounds or damaged skin due to the risk of exacerbating the condition and causing further irritation.

• Concurrent use with a heating pad, as this may increase the risk of skin burns or irritation.

• In individuals with known allergies to any ingredients in this product, as this may lead to severe allergic reactions.

Additionally, if a rash, itching, or excessive skin irritation develops, or if the condition worsens or persists for more than 7 days, discontinuation of use is advised. Avoid contact with eyes, mucous membranes, or rashes, and do not apply tightly bandaged or in conjunction with other topical analgesics.

Warnings and Precautions

For external use only. It is imperative that this product is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

General precautions must be observed to ensure safe usage. This product should not be applied to wounds or damaged skin, nor should it be used in conjunction with a heating pad. Additionally, individuals with known allergies to any of the product's ingredients should refrain from using it.

Healthcare professionals should advise patients to discontinue use and seek medical advice if any of the following occur: the development of a rash, itching, or excessive skin irritation; worsening of the condition; or if symptoms persist beyond 7 days or resolve only to recur within a few days. Monitoring for these adverse reactions is essential to ensure patient safety and effective management of their condition.

Side Effects

For external use only. Patients should be advised to discontinue use if rash, itching, or excessive skin irritation develops. In such cases, it is important to monitor the condition closely. If the condition worsens or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients should seek medical advice. These adverse reactions highlight the need for careful observation during treatment to ensure patient safety and effective management of any emerging issues.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may increase the risk of adverse effects without providing additional therapeutic benefit. It is advised to avoid using multiple topical analgesics simultaneously to ensure patient safety and efficacy of treatment.

No specific interactions with laboratory tests have been identified. Therefore, routine monitoring of laboratory parameters is not necessary when this medication is administered.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Patch (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored when using this product, as used patches still contain the drug and can pose serious risks if ingested by children or pets. It is crucial to dispose of used patches properly to prevent accidental exposure.

Healthcare professionals should advise caregivers to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the potential for altered pharmacokinetics and pharmacodynamics in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Use is contraindicated in pregnancy due to potential risks to the fetus. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use to discuss potential risks and benefits.

Lactation

There are no specific statements regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the context of overdosage, there is currently no specific information available regarding the effects or management of an overdose for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse reactions that may arise.

In the absence of detailed overdosage data, it is recommended that standard supportive measures be employed. This includes ensuring the patient's safety, providing symptomatic treatment, and considering the use of activated charcoal if the ingestion occurred within a timeframe that warrants its use.

Healthcare providers should remain vigilant and report any observed adverse effects to the appropriate regulatory authorities to enhance the understanding of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified that used patches may still contain the drug product, which can lead to serious adverse effects if chewed or ingested by children or pets. This information has been reported voluntarily and through surveillance programs, highlighting the importance of proper disposal and storage of used patches to mitigate potential risks.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to use the medication only as directed. It is important to emphasize the need to avoid contact with the eyes, mucous membranes, or any rashes. Providers should also counsel patients against bandaging the area tightly and to refrain from using the product concurrently with other topical analgesics.

Additionally, healthcare providers should instruct patients on the proper disposal of used patches. Patients must be made aware that used patches still contain the drug product, which can pose serious risks if ingested by children or pets. Therefore, it is crucial to dispose of them in a manner that ensures they are kept away from children and pets.

Storage and Handling

The product is supplied in a clean, dry container designed to protect it from excessive moisture and direct sunlight. It is essential to store the product in a location that maintains these conditions to ensure its integrity and efficacy.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients on the proper disposal of used patches to prevent accidental exposure to children and pets, as these patches may still contain active drug that can lead to serious adverse effects if ingested. Patients are advised to seek medical attention if they experience rash, itching, or excessive skin irritation, if their condition worsens, or if symptoms persist beyond 7 days or recur shortly after resolution. Additionally, it is crucial to keep the product out of reach of children, and in the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

Drug Information (PDF)

This file contains official product information for Pain Relief Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)